According to the latest Renub Research report, titled “Specialty Pharmaceuticals Market in the United States & forecast by application (oncology, autoimmune, immunology, HIV, multiple sclerosis, hematology, AMD, HGH, others), companies â The growing aging population is fueling the US specialty pharmacy market. More than 20% of the US population is over 65, and that age number is expected to increase by 2026. Apart from that, increasing purchasing power and access to health care and to quality pharmaceuticals for poor families and the growing middle class of the specialty pharmaceutical industry in the United States. Growth engines for specialty pharmacy include new drugs on the market, expansion of hospital pharmacies and more chronic disease diagnostics. According to Renub Research Analysis, the US specialty pharmaceutical market is expected to reach $ 387 billion by 2026.
The US pharmaceutical market is divided into two main types of drugs namely traditional drugs and specialty drugs. In recent years, specialty drugs have gained a strong foothold in the United States. Specialty drugs are intended for life-threatening and rare chronic diseases. Drugs in this category are difficult to administer and very expensive. In addition, these drugs require good management and exceptional handling, which makes them expensive. As a considerable portion of the population of the United States ages in diseases like cancer and other life-threatening chronic diseases, the demand for specialty drugs has skyrocketed in recent years. Because of this the world’s largest pharmaceutical companies are directing their research and development initiatives in the specialty drug.
Request a free copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-states-specialty-pharmaceuticals-market-p.php
Over the past decade, the US specialty pharmaceutical market has changed, with many specialty drugs in their final stages of development. The US Specialty Pharmaceuticals market will experience accelerated growth over the next few years, mainly due to factors such as improving life expectancy, aging US population, increasing actual spending net per capita in specialty drugs and high prevalence of chronic disease. In the region. About 50% of all new specialty drugs approved by the FDA in 2018 were originally developed by companies other than those that received the approval.
Market growth is likely to be challenged by the discontinuation rate of specialty drugs and high R&D costs. The top five pharmaceutical companies covered by the report are UnitedHealth Group Incorporated, Recordati Pharmaceuticals, CVS Health and Endo International.
Follow the link for the full report with detailed table of contents and list of figures and tables: https://www.renub.com/united-states-specialty-pharmaceuticals-market-p.php
By application: The market and pipeline of Oncology, Autoimmunity, Immunology, HIV, Multiple Sclerosis, Hematology, Age-Related Macular Degeneration (AMD), Other human growth hormones (HGH) are covered in this research report.
By company: Company overview, products / initiatives and financial overview of CVS Health, Endo International, UnitedHealth Group Incorp and Recordati Pharmaceuticals are presented in this research report.
Industry related opportunity:
Generic Drugs Market in United States: https://www.renub.com/united-states-generic-drugs-market-p.php
Allergic Conjunctivitis Market: https://www.renub.com/allergic-conjunctivitis-market-p.php
Swedish Diabetes Market: https://www.renub.com/sweden-diabetes-market-p.php
Diabetes Market in United States: https://www.renub.com/united-states-diabetes-market-p.php
Global Diabetes Drugs Market: https://www.renub.com/diabetes-drug-market-p.php
Chinese Cancer Drugs Market: https://www.renub.com/china-cancer-drugs-market-p.php
About the company:
Renub Research is a market research and consulting company. We have over 10 years of experience, particularly in international business-to-business research, surveys and advice. We offer a wide range of business research solutions that help businesses make better business decisions. We partner with clients across industries and regions to identify their most important opportunities, address their most critical challenges and transform their businesses. Our large clientele is made up of major players in the Health care, Travel and tourism, food and drink, electricity and energy, information technology, telecommunications and the Internet, chemicals, logistics and automotive, consumer goods and retail, building and construction, and agriculture. Our clients rely on our market analysis and data to make informed decisions. We are considered one of the best knowledge providers. Our insightful analysis helps consultants, bankers and executives make informed and correct decisions.
Our core team is made up of experienced people with graduate, postgraduate and doctoral degrees in finance, marketing, human resources, biotechnology, medicine, information technology, environmental science and many more. other. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers and acquisitions, etc. We support many leading companies by providing them with insight and insight into a wide range of markets. Our research reports offer a blend of essential information, analysis and forecasting in today’s ultra-competitive markets.
Phone number: +1 678-302-0700 (US) | + 91-120-421-9822 (IND)
E-mail: [email protected]
The Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research